Condition (MeSH)
Drug Hypersensitivity Syndrome
ClinicalTrials.gov lists 7 trials for Drug Hypersensitivity Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Drug Hypersensitivity Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Drug Hypersensitivity Syndrome trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 1
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 2 |
| 2020 | 1 |
| 2014 | 1 |
| 2013 | 2 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Drug Hypersensitivity Syndrome trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Not applicable | 2 |
| Observational | 3 |
How many Drug Hypersensitivity Syndrome trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Completed | 2 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Drug Hypersensitivity Syndrome? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial. | Journal of the American Academy of Dermatology | 2024 | Yes |
| Vancomycin-associated drug-induced hypersensitivity syndrome. | Journal of the American Academy of Dermatology | 2019 | Yes |
| Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy. | Molecules (Basel, Switzerland) | 2019 | Yes |
| Severe cutaneous adverse reactions to drugs. | Lancet (London, England) | 2017 | Yes |
| Therapeutic management of DRESS: a retrospective study of 38 cases. | Journal of the American Academy of Dermatology | 2015 | Yes |
Showing 5 of 9 publications.
Prevalence (1)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Drug reaction with eosinophilia and systemic symptoms | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.